Files in This Item:


Title: Report of the global programme managers' meeting on leprosy control strategy
Other Titles: New Delhi, India, 20-22 April 2009
Authors: World Health Organization, Regional Office for South-East Asia
Issue Date: 2009
Publisher: WHO Regional Office for South-East Asia
Place of publication: New Delhi
Language: English
Abstract: The Global Programme Managers' Meeting on Leprosy Control was held in the South-East Asia Regional Office of the World Health Organization on 20-22 April 2009. The objective of the meeting was "to develop the Enhanced Global Strategy for 2011-2015 and the updated Operational Guidelines". The meeting was attended by 120 participants including national programme managers from 45 countries representing all Regions of WHO (except Europe), experts from various fields such as social scientists, rehabilitation officials and persons affected by leprosy, and representatives from major partners such as The Nippon Foundation (TNF), Sasakawa Memorial Health Foundation (SMHF), Novartis Foundation for Sustainable Development, International Federation of Anti-Leprosy Association (ILEP), International Leprosy Association (ILA) and the International Association for Integration, Dignity and Economic Advancement (IDEA). The highlights of the Enhanced Strategy are to: strengthen integration to sustain leprosy control activities as the disease burden declines further; improve quality of services which includes prevention of disabilities, rehabilitation and reducing stigma and discrimination; strengthen referral services in an integrated approach to support the primary health care system; monitor progress of the programme globally by using new cases with grade-2 disabilities rate per 100000 population as a target, and to reduce it by 35% in 2015 from the baseline of 2010; improve capacity building at the international, national and peripheral level so as to enhance expertise level, in countries dealing with leprosy; closely monitor the leprosy situation in countries to ensure that the burden of the disease continues to decline further; carry out drug resistance surveillance to monitor the situation, and promote research with the aim to develop new drugs and explore the use of chemoprophylaxis. The Enhanced Global Strategy 2011-2015 and the Updated Operational Guidelines were endorsed by all participants.
Keywords: LEPROSY
Gov't Doc #: SEA-GLP-2009.6
Appears in Collections:Meeting Reports

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.